{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T11:38:03Z","timestamp":1784806683393,"version":"3.55.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Boehringer Ingelheim"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s13555-025-01392-4","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T07:44:41Z","timestamp":1743666281000},"page":"1153-1161","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Generalized Pustular Psoriasis Brazilian Experts Survey: Challenges in Disease Management"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0165-3831","authenticated-orcid":false,"given":"Ricardo","family":"Romiti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0407-538X","authenticated-orcid":false,"given":"Andr\u00e9 V. E.","family":"de Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9721-2963","authenticated-orcid":false,"given":"Cinara P. C. C.","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4160-5447","authenticated-orcid":false,"given":"Gleison","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,1]]},"reference":[{"key":"1392_CR1","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1111\/jdv.14386","volume":"31","author":"AA Navarini","year":"2017","unstructured":"Navarini AA, Burden AD, Capon F, et\u00a0al. European consensus statement on phenotypes of pustular psoriasis. J Eur Acad Dermatol Venereol. 2017;31:1792\u20139.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1392_CR2","doi-asserted-by":"crossref","unstructured":"Romiti R, Hirayama AL da S, Arnone M, Magalh\u00e3es RF. Generalized pustular psoriasis (von Zumbusch). Anais Brasileiros de Dermatologia. 2022;97:63\u201374.","DOI":"10.1016\/j.abd.2021.05.011"},{"key":"1392_CR3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jdin.2021.12.001","volume":"6","author":"GV Duarte","year":"2022","unstructured":"Duarte GV, Esteves de Carvalho AV, Romiti R, et\u00a0al. Generalized pustular psoriasis in Brazil: a public claims database study. JAAD Int. 2022;6:61\u20137.","journal-title":"JAAD Int"},{"key":"1392_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s40257-021-00652-1","volume":"23","author":"H Fujita","year":"2022","unstructured":"Fujita H, Gooderham M, Romiti R. Diagnosis of generalized pustular psoriasis. Am J Clin Dermatol. 2022;23:31\u20138.","journal-title":"Am J Clin Dermatol"},{"key":"1392_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s40257-021-00664-x","volume":"23","author":"M Zheng","year":"2022","unstructured":"Zheng M, Jullien D, Eyerich K. The prevalence and disease characteristics of generalized pustular psoriasis. Am J Clin Dermatol. 2022;23:5\u201312.","journal-title":"Am J Clin Dermatol"},{"key":"1392_CR6","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1080\/1744666X.2022.2116003","volume":"18","author":"H Bachelez","year":"2022","unstructured":"Bachelez H, Barker J, Burden AD, Navarini AA, Krueger JG. Generalized pustular psoriasis is a disease distinct from psoriasis vulgaris: evidence and expert opinion. Expert Rev Clin Immunol. 2022;18:1033\u201347.","journal-title":"Expert Rev Clin Immunol"},{"key":"1392_CR7","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s40257-021-00663-y","volume":"23","author":"DV Reisner","year":"2022","unstructured":"Reisner DV, Johnsson FD, Kotowsky N, Brunette S, Valdecantos W, Eyerich K. Impact of generalized pustular psoriasis from the perspective of people living with the condition: results of an online survey. Am J Clin Dermatol. 2022;23:65\u201371.","journal-title":"Am J Clin Dermatol"},{"key":"1392_CR8","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/1346-8138.17097","volume":"51","author":"Y Tada","year":"2024","unstructured":"Tada Y, Guan J, Iwasaki R, Morita A. Treatment patterns and drug survival for generalized pustular psoriasis: a patient journey study using a Japanese claims database. J Dermatol. 2024;51:391\u2013402.","journal-title":"J Dermatol"},{"key":"1392_CR9","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1111\/1346-8138.14523","volume":"45","author":"H Fujita","year":"2018","unstructured":"Fujita H, Terui T, Hayama K, et\u00a0al. Japanese guidelines for the management and treatment of generalized pustular psoriasis: the new pathogenesis and treatment of GPP. J Dermatol. 2018;45:1235\u201370.","journal-title":"J Dermatol"},{"key":"1392_CR10","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/jdv.18851","volume":"37","author":"L Puig","year":"2023","unstructured":"Puig L, Choon SE, Gottlieb AB, et\u00a0al. Generalized pustular psoriasis: a global Delphi consensus on clinical course, diagnosis, treatment goals and disease management. J Eur Acad Dermatol Venereol. 2023;37:737\u201352.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1392_CR11","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s13555-021-00493-0","volume":"11","author":"B Strober","year":"2021","unstructured":"Strober B, Kotowsky N, Medeiros R, et\u00a0al. Unmet medical needs in the treatment and management of generalized pustular psoriasis flares: evidence from a survey of Corrona registry dermatologists. Dermatol Ther (Heidelb). 2021;11:529\u201341.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"16","key":"1392_CR12","doi-asserted-by":"publisher","first-page":"9048","DOI":"10.3390\/ijms22169048","volume":"22","author":"D Samotij","year":"2021","unstructured":"Samotij D, Szcz\u0119ch J, Reich A. Generalized pustular psoriasis: divergence of innate and adaptive immunity. Int J Mol Sci. 2021;22(16):9048.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"1392_CR13","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1056\/NEJMoa1013068","volume":"365","author":"S Marrakchi","year":"2011","unstructured":"Marrakchi S, Guigue P, Renshaw BR, et\u00a0al. Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N Engl J Med. 2011;365(7):620\u20138.","journal-title":"N Engl J Med"},{"issue":"10","key":"1392_CR14","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.3389\/fimmu.2019.02532","volume":"31","author":"ZC Yuan","year":"2019","unstructured":"Yuan ZC, Xu WD, Liu XY, Liu XY, Huang AF, Su LC. Biology of IL-36 signaling and its role in systemic inflammatory diseases. Front Immunol. 2019;31(10):2532.","journal-title":"Front Immunol"},{"key":"1392_CR15","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1056\/NEJMoa2111563","volume":"385","author":"H Bachelez","year":"2021","unstructured":"Bachelez H, Choon S-E, Marrakchi S, et\u00a0al. Trial of spesolimab for generalized pustular psoriasis. N Engl J Med. 2021;385:2431\u201340.","journal-title":"N Engl J Med"},{"key":"1392_CR16","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1016\/S0140-6736(23)01378-8","volume":"402","author":"A Morita","year":"2023","unstructured":"Morita A, Strober B, Burden AD, et\u00a0al. Efficacy and safety of subcutaneous spesolimab for the prevention of generalised pustular psoriasis flares (Effisayil 2): an international, multicentre, randomised, placebo-controlled trial. Lancet. 2023;402:1541\u201351.","journal-title":"Lancet"},{"issue":"5","key":"1392_CR17","doi-asserted-by":"publisher","first-page":"e437","DOI":"10.1111\/jdv.19678","volume":"38","author":"F Bellinato","year":"2024","unstructured":"Bellinato F, Gisondi P, Dattola A, et\u00a0al. Spesolimab in patients with flare of generalized pustular psoriasis: a multicentre case-series. J Eur Acad Dermatol Venereol. 2024;38(5):e437\u20139.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1392_CR18","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s40257-024-00906-8","volume":"26","author":"J Yeung","year":"2025","unstructured":"Yeung J, Sood S. Real-world experience of spesolimab for generalized pustular psoriasis flares in adult patients: a multicenter retrospective study. Am J Clin Dermatol. 2025;26:151\u20133.","journal-title":"Am J Clin Dermatol"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-025-01392-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-025-01392-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-025-01392-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T17:29:47Z","timestamp":1745688587000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-025-01392-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["1392"],"URL":"https:\/\/doi.org\/10.1007\/s13555-025-01392-4","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,1]]},"assertion":[{"value":"4 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Boehringer Ingelheim was given the opportunity to review the manuscript for medical and scientific accuracy as well as intellectual property considerations. Dr Ricardo Romiti served as a scientific consultant, speaker, or clinical study investigator for AbbVie, Boehringer Ingelheim, Galderma, Janssen-Cilag, Eli-Lilly, Leo-Pharma, Novartis, Pfizer, TEVA, and UCB. Dr Andr\u00e9 Vicente Esteves de Carvalho received grants, consultancy, and speaking honoraria from AbbVie, Janssen, LeoPharma, Boehringer Ingelheim, Novartis, Eli-Lilly, and UCB. Dr Cinara Prata Cirino Castro Soares is an employee of Boehringer Ingelheim do Brasil. Dr Gleison Duarte received grants, consultancy and speaking honoraria from AbbVie, Bayer, Biolab, Boehringer, Ingelheim, Galderma, Janssen, Eli-Lilly, LeoPharma, UCB, Novartis, and Pfizer.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"In Brazil, a public opinion survey without the possibility of identifying the participant should not be submitted for examination by the Conep System. In Brazil, public opinion polls, without the possibility of identifying the participant, should not be submitted for examination by the ethics committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}